Advertisement
Advertisement

Read Now: News and Research From IDWeek 2014

Prevention/Epidemiology

Science Magazine Examines Recent HIV Vaccine Clinical Trial Results

May 10, 2013

Science magazine reviews the disappointing results of two recent HIV vaccine clinical trials, which "sugges[t] that a successful vaccine, the most effective way to slow if not end the epidemic, lies far in the future." The news service focuses on the experimental vaccines' use of adenovirus vectors, which "are widely used in experimental vaccines and gene therapy studies" and show some evidence of increasing the risk of HIV infection. "Other than a large-scale trial of a new and improved version of RV144 set to start in South Africa in 2015, all HIV trials currently in the works are at very early stages," Science notes (Cohen, 5/10).

Back to other news for May 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement